Company / SG&A Expense
InspireMD, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$15.3M
FY2025
5-year range
$6.1M / $15.3M
FY2021-FY2025
Trend
+37.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has increased for 6 consecutive years, from $5M in FY2019 to $15M in FY2025.
Based on SEC 10-K filings.
$15M in FY2025 with a 5-year CAGR of +24.0%.
Increased from $8M to $15M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +27.4%
- 5-Year CAGR
- +24.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- InspireMD, Inc.'s sg&a expense has grown for 6 consecutive years.
- 5-year CAGR of +24.0%, indicating consistent growth.
- In FY2025, sg&a expense increased 37.8% year-over-year.
- Lowest sg&a expense in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.3M | +37.8% |
| FY2024 | $11.1M | +32.9% |
| FY2023 | $8.4M | +12.8% |
| FY2022 | $7.4M | +20.9% |
| FY2021 | $6.1M | +17.3% |
| FY2020 | $5.2M | +8.1% |
| FY2019 | $4.8M | -6.8% |
| FY2018 | $5.2M | +3.7% |
| FY2017 | $5.0M | -21.7% |
| FY2016 | $6.4M | -30.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026